Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A(TW:1762)
NT$32.75+1.70 (+5.48%)
TW:1762
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A ownership
NT$32.75
At close:+1.70 (+5.48%)
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Ownership - Who Owns Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Ownership Overview
- 0.25% ETFs
- 99.75% Public Companies and Individual Investors
The ownership structure of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is a mix of institutional, retail, and individual investors. Approximately 0.25% of the company’s stock is owned by Institutional Investors, and 99.75% is owned by Public Companies and Individual Investors.
The ownership structure of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is a mix of institutional, retail, and individual investors. Approximately 0.25% of the company’s stock is owned by Institutional Investors, and 99.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Avantis | 113,000 | Institution | 0.15% | 112,435 |
| Dimensional | 81,000 | Institution | 0.11% | 80,595 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Avantis Emerging Markets Equity ETF, AVEM ETF | 98,000 | Institution | 0.13% | 92,524 |
| Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF | 47,000 | Institution | 0.06% | 44,273 |
| Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF | 21,000 | Institution | 0.03% | 19,782 |
| Avantis Emerging Markets Value ETF, AVES ETF | 14,000 | Institution | 0.02% | 13,218 |
| Dimensional Emerging Core Equity Market ETF, DFAE ETF | 13,000 | Institution | 0.02% | 12,246 |
| Avantis Responsible Emerging Markets Equity ETF, AVSE ETF | 1,000 | Institution | <0.01% | 944 |
FAQ
What percentage of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.25% of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is held by institutional investors.
What percentage of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.75% of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762) stock is held by public companies and individual investors.
Who owns the most shares of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762)?
Avantis owns the most shares of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (TW:1762).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
